Correlation Between Akums Drugs and Emcure Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Akums Drugs and Emcure Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akums Drugs and Emcure Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Akums Drugs and and Emcure Pharmaceuticals, you can compare the effects of market volatilities on Akums Drugs and Emcure Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akums Drugs with a short position of Emcure Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akums Drugs and Emcure Pharmaceuticals.

Diversification Opportunities for Akums Drugs and Emcure Pharmaceuticals

0.57

Correlation Coefficient

Akums Drugs  Emcure Pharmaceuticals

Very weak diversification

The 3 months correlation between Akums and Emcure is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Akums Drugs and and Emcure Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emcure Pharmaceuticals and Akums Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akums Drugs and are associated (or correlated) with Emcure Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emcure Pharmaceuticals has no effect on the direction of Akums Drugs i.e., Akums Drugs and Emcure Pharmaceuticals go up and down completely randomly.

Pair Corralation between Akums Drugs and Emcure Pharmaceuticals

Assuming the 90 days trading horizon Akums Drugs and is expected to under-perform the Emcure Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Akums Drugs and is 1.08 times less risky than Emcure Pharmaceuticals. The stock trades about -0.05 of its potential returns per unit of risk. The Emcure Pharmaceuticals is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  100,800  in Emcure Pharmaceuticals on October 15, 2024 and sell it today you would earn a total of  31,025  from holding Emcure Pharmaceuticals or generate 30.78% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	84.62%
Values	Daily Returns

Akums Drugs and  vs.  Emcure Pharmaceuticals

Akums Drugs

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Akums Drugs and has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Emcure Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Emcure Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Akums Drugs and Emcure Pharmaceuticals

The main advantage of trading using opposite Akums Drugs and Emcure Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akums Drugs position performs unexpectedly, Emcure Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emcure Pharmaceuticals will offset losses from the drop in Emcure Pharmaceuticals' long position.

The idea behind Akums Drugs and and Emcure Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.